News | June 10, 2019

Deciphera Pharmaceuticals, Inc. Expands Pipeline with Potential First-in-Class Autophagy Inhibitor to Treat Mutant RAS Cancers -DCC-3116 Selectively Targets ULK Kinase, an Initiating Protein that Activates Autophagy – -Company to Host a Webcast on Tuesday, June...

News | June 10, 2019

Aptinyx Reports Positive Top-line Data from Phase 2 Study of NYX-2925 in Patients with Fibromyalgia, Demonstrating Significant Effects on Both Biomarkers and Patient-Reported Pain NYX-2925 demonstrated statistically significant effects on a range of neuroimaging...

News | April 4, 2019

TigerConnect Named a Top Technology Company in Santa Monica 04.25.19 In the News Home / Newsroom /TigerConnect Named a Top Technology Company in Santa Monica Originally posted in The Tech Tribune Best Technology Company in Santa MonicaThe Tech Tribune staff has...

News | May 29, 2019

ARVINAS RECEIVES FAST TRACK DESIGNATION FOR ITS TARGETED PROTEIN DEGRADER ARV-110 AS A TREATMENT FOR MEN WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER ARV-110 is Arvinas’ first clinical-stage drug in the innovative field of targeted protein degradation,...

News | May 15, 2019

TigerConnect Names Sarah Shillington SVP of Client Success Shillington Brings 25 Years of Healthcare Experience Overseeing Client Success at Large-Scale, Global Enterprise Companies SANTA MONICA, CA – May 15, 2019 – TigerConnect, provider of healthcare’s most...

News | April 17, 2019

Newly-Formed Prisma Health Selects Kyruus Solutions to Optimize Patient Access and Provider Network Management Post-Merger South Carolina’s Largest Health System to Leverage Digital Solutions to Drive Systemness Boston, MA – Kyruus, a leader in provider search and...